{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:42:58Z","timestamp":1759160578367,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ajo.2010.11.029","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T05:55:17Z","timestamp":1299822917000},"page":"999-1006.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Association of Host Genetic Risk Factors With the Course of Cytomegalovirus Retinitis in Patients Infected With Human Immunodeficiency Virus"],"prefix":"10.1016","volume":"151","author":[{"given":"Efe","family":"Sezgin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"van Natta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Troyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2010.11.029_bib1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ajo.2010.11.029_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2010.11.029_bib3","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"10.1016\/j.ajo.2010.11.029_bib4","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ajo.2010.11.029_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0197-2456(92)90027-W","article-title":"Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1","volume":"13","year":"1992","journal-title":"Control Clin Trials"},{"issue":"8","key":"10.1016\/j.ajo.2010.11.029_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ophtha.2006.03.022","article-title":"Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2010.11.029_bib7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2006.03.021","article-title":"Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"issue":"14","key":"10.1016\/j.ajo.2010.11.029_bib8","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.ajo.2010.11.029_bib9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/archopht.126.8.1143","article-title":"AIDS and ophthalmology, 2008","volume":"126","author":"Jabs","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2010.11.029_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2004.10.049","article-title":"Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy","volume":"112","author":"Jabs","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2010.11.029_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","article-title":"Longitudinal study of the ocular complications of AIDS: 1","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2010.11.029_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.ajo.2010.11.029_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ajo.2010.11.029_bib14","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ophtha.2004.05.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2010.11.029_bib15","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2004.05.028","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2010.11.029_bib16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/319219","article-title":"Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution","volume":"32","author":"Johnson","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ajo.2010.11.029_bib17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/319683","article-title":"Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis","volume":"183","author":"Komanduri","year":"2001","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ajo.2010.11.029_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002030-200001280-00013","article-title":"CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy","volume":"14","author":"Torriani","year":"2000","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.ajo.2010.11.029_bib19","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ophtha.2010.03.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2010.11.029_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ng1369","article-title":"Human genes that limit AIDS","volume":"36","author":"O'Brien","year":"2004","journal-title":"Nat Genet"},{"issue":"Suppl 4","key":"10.1016\/j.ajo.2010.11.029_bib21","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00002030-200317004-00006","article-title":"The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy","volume":"17","author":"Tang","year":"2003","journal-title":"AIDS"},{"issue":"5283","key":"10.1016\/j.ajo.2010.11.029_bib22","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","article-title":"Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene","volume":"273","author":"Dean","year":"1996","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ajo.2010.11.029_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QAI.0b013e31816fdc5f","article-title":"Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival","volume":"48","author":"Hendrickson","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.ajo.2010.11.029_bib24","first-page":"323","article-title":"Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients","volume":"5","author":"Kasten","year":"2000","journal-title":"Eur J Med Res"},{"issue":"7","key":"10.1016\/j.ajo.2010.11.029_bib25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00002030-200005050-00008","article-title":"Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy","volume":"14","author":"O'Brien","year":"2000","journal-title":"AIDS"},{"issue":"5328","key":"10.1016\/j.ajo.2010.11.029_bib26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.277.5328.959","article-title":"Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression","volume":"277","author":"Smith","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ajo.2010.11.029_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1468-1293.2004.00219.x","article-title":"Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type","volume":"5","author":"Bogner","year":"2004","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.ajo.2010.11.029_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/aid.2006.22.153","article-title":"Analysis of CCR5, CCR2, CX3CR1, and SDF1 polymorphisms in HIV-positive treated patients: impact on response to HAART and on peripheral T lymphocyte counts","volume":"22","author":"Puissant","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"10.1016\/j.ajo.2010.11.029_bib29","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1086\/345677","article-title":"CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients","volume":"186","author":"Wit","year":"2002","journal-title":"J Infect Dis"},{"issue":"5395","key":"10.1016\/j.ajo.2010.11.029_bib30","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1126\/science.282.5395.1907","article-title":"Genetic acceleration of AIDS progression by a promoter variant of CCR5","volume":"282","author":"Martin","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ajo.2010.11.029_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/157016209788680543","article-title":"Molecular phenotype of CXCL12beta 3'UTR G801A polymorphism (rs1801157) associated to HIV-1 disease progression","volume":"7","author":"Garcia-Moruja","year":"2009","journal-title":"Curr HIV Res"},{"issue":"11","key":"10.1016\/j.ajo.2010.11.029_bib32","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/324427","article-title":"Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy","volume":"184","author":"Lathey","year":"2001","journal-title":"J Infect Dis"},{"issue":"5349","key":"10.1016\/j.ajo.2010.11.029_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.279.5349.389","article-title":"Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant","volume":"279","author":"Winkler","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ajo.2010.11.029_bib34","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1073\/pnas.97.4.1695","article-title":"Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)","volume":"97","author":"Kotenko","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.ajo.2010.11.029_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nri932","article-title":"Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance","volume":"2","author":"Reddehase","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.ajo.2010.11.029_bib36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1086\/654814","article-title":"Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS","volume":"202","author":"Sezgin","year":"2010","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.ajo.2010.11.029_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ophtha.2006.07.065","article-title":"Longitudinal study of the ocular complications of AIDS: 2","volume":"114","author":"Jabs","year":"2007","journal-title":"Ophthalmology"},{"issue":"21","key":"10.1016\/j.ajo.2010.11.029_bib38","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/sim.4780132105","article-title":"Cox regression analysis of multivariate failure time data: the marginal approach","volume":"13","author":"Lin","year":"1994","journal-title":"Stat Med"},{"issue":"14","key":"10.1016\/j.ajo.2010.11.029_bib39","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/00002030-200009290-00007","article-title":"Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans","volume":"14","author":"An","year":"2000","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.ajo.2010.11.029_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/315650","article-title":"Shorter survival of SDF1-3'A\/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection","volume":"182","author":"Brambilla","year":"2000","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.ajo.2010.11.029_bib41","doi-asserted-by":"crossref","first-page":"F85","DOI":"10.1097\/00002030-199809000-00002","article-title":"The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection","volume":"12","author":"van Rij","year":"1998","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.ajo.2010.11.029_bib42","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1086\/496893","article-title":"Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression","volume":"192","author":"Daar","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ajo.2010.11.029_bib43","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/JVI.76.3.1285-1292.2002","article-title":"Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10","volume":"76","author":"Spencer","year":"2002","journal-title":"J Virol"},{"issue":"5\u20136","key":"10.1016\/j.ajo.2010.11.029_bib44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000053970","article-title":"Molecular mimicry by cytomegaloviruses","volume":"42","author":"Vink","year":"1999","journal-title":"Intervirology"},{"issue":"23","key":"10.1016\/j.ajo.2010.11.029_bib45","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1073\/pnas.84.23.8642","article-title":"Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus","volume":"84","author":"Davis","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ajo.2010.11.029_bib46","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/BF01314968","article-title":"HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretors","volume":"140","author":"Margalith","year":"1995","journal-title":"Arch Virol"},{"issue":"6259","key":"10.1016\/j.ajo.2010.11.029_bib47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/343659a0","article-title":"HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor","volume":"343","author":"McKeating","year":"1990","journal-title":"Nature"},{"issue":"9427","key":"10.1016\/j.ajo.2010.11.029_bib48","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","article-title":"Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy","volume":"363","author":"Deayton","year":"2004","journal-title":"Lancet"},{"issue":"Pt 8","key":"10.1016\/j.ajo.2010.11.029_bib49","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1099\/vir.0.81452-0","article-title":"Human cytomegalovirus modulation of CCR5 expression on myeloid cells affects susceptibility to human immunodeficiency virus type 1 infection","volume":"87","author":"King","year":"2006","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.ajo.2010.11.029_bib50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.184.3.1101","article-title":"A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)","volume":"184","author":"Bleul","year":"1996","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.ajo.2010.11.029_bib51","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.187.5.753","article-title":"B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement","volume":"187","author":"Bleul","year":"1998","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.ajo.2010.11.029_bib52","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4049\/jimmunol.169.3.1365","article-title":"The Rap GTPases regulate B cell migration toward the chemokine stromal cell-derived factor-1 (CXCL12): potential role for Rap2 in promoting B cell migration","volume":"169","author":"McLeod","year":"2002","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.ajo.2010.11.029_bib53","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2003-12-4423","article-title":"SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells","volume":"104","author":"De Falco","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ajo.2010.11.029_bib54","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.eye.6702342","article-title":"Expression of chemokines and gelatinase B in sympathetic ophthalmia","volume":"21","author":"Abu El-Asrar","year":"2007","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.ajo.2010.11.029_bib55","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ophtha.2007.08.050","article-title":"Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity","volume":"115","author":"Sonmez","year":"2008","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2010.11.029_bib56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.exer.2004.02.006","article-title":"Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis","volume":"78","author":"Fang","year":"2004","journal-title":"Exp Eye Res"},{"issue":"12","key":"10.1016\/j.ajo.2010.11.029_bib57","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/archopht.122.12.1801","article-title":"Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone","volume":"122","author":"Brooks","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2010.11.029_bib58","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI22869","article-title":"SDF-1 is both necessary and sufficient to promote proliferative retinopathy","volume":"115","author":"Butler","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ajo.2010.11.029_bib59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2170\/jjphysiol.53.53","article-title":"Local changes of IGF-I mRNA, GH receptor mRNA, and fiber size in rat plantaris muscle following compensatory overload","volume":"53","author":"Yamaguchi","year":"2003","journal-title":"Jpn J Physiol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293941000958X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293941000958X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:04:11Z","timestamp":1757595851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293941000958X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S000293941000958X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2010.11.029","relation":{},"ISSN":["0002-9394"],"issn-type":[{"type":"print","value":"0002-9394"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Host Genetic Risk Factors With the Course of Cytomegalovirus Retinitis in Patients Infected With Human Immunodeficiency Virus","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2010.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}